JERUSALEM, December 1, 2014 /PRNewswire/ —
Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (https://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that Company management will participate in the upcoming LD MICRO “Main Event” Micro-Cap Growth Conference taking place from December 2-4, 2014 in Los Angeles. Michael Berelowitz, M.D., Director and Chairman of the Scientific Advisory Board of Oramed, will present a corporate overview on Tuesday, December 2, 2014 at 5:00 p.m. PST (8:00 p.m. EST).
About Oramed Pharmaceuticals
Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, Oramed’s Protein Oral Delivery (POD